REVEAL DX
Report
- Report Number
- 6000144-2010-03236
- Event Type
- Malfunction
- Date Received
- August 11, 2010
- Date of Event
- May 4, 2010
- Manufacturer
- MEDTRONIC MED REL, INC.
- Product Code
- DSI
- PMA / PMN Number
- K071655
- Removal / Correction Number
- ASKU
- Report Source
- Manufacturer report
- Reporter Location
- MN, US
- Reporter Occupation
- MEDICAL EQUIPMENT COMPANY TECHNICIAN/REPRESENTATIVE
Narratives
THE INFORMATION SUBMITTED REFLECTS ALL RELEVANT DATA RECEIVED. IF ADDITIONAL RELEVANT INFORMATION IS RECEIVED, A SUPPLEMENTAL REPORT WILL BE SUBMITTED.
THE INFORMATION SUBMITTED REFLECTS ALL RELEVANT DATA RECEIVED. IF ADDITIONAL RELEVANT INFORMATION IS RECEIVED, A SUPPLEMENTAL REPORT WILL BE SUBMITTED. UNCHECKED EXPLANTED FOR DEVICE 1. EVALUATION SUMMARY: (B)(4) THE ACTUAL DEVICE WAS NOT RECEIVED FOR EVALUATION. WE DID RECEIVE PERFORMANCE DATA COLLECTED FROM THE DEVICE AND HAVE ANALYZED THE DATA. PRIMARY ANALYSIS FINDING: SENSING (OTHER) WAS NOTED. THE LIFETIME FVT EPISODE COUNTER WAS AT 2469, THE LIFETIME ASYSTOLE EPISODE COUNTER WAS AT 57, AND THE LIFETIME TIME IN NOISE COUNTER WAS AT 70765086.
THE REPORT RECEIVED INDICATED THE PATIENT EXPERIENCED A SYMPTOMATIC EPISODE: LIGHTHEADEDNESS BUT DID NOT ACTIVATE PATIENT ASSISTANT. THEREFORE, NO EPISODE WERE RECORDED ON THE DEVICE AT THE TIME OF THE EVENT. HOWEVER, SEVERAL NOISE EPISODES WERE SUBSEQUENTLY RECORDED AS FAST VENTRICULAR TACHYARRHYTHMIA OR FIBRILLATION (FVT), AND THERE WERE TWO ASYSTOLE EPISODES RECORDINGS DUE TO UNDERSENSING. CONSEQUENTLY, THE FOLLOWING ACTIONS WERE RECOMMENDED: REPROGRAM FVT INTERVAL FROM 300 TO 260 MILLISECONDS AND FVT DURATION FROM 9/12 TO 30/40. ADDITIONALLY, SENSITIVITY PROGRAM TO 0.025MV DUE TO UNDERSENSING EPISODES. NO PATIENT COMPLICATIONS HAVE BEEN REPORTED AS A RESULT OF THIS EVENT.
Devices
| Seq | Brand | Generic | Product Code | Manufacturer | Model | Lot | UDI-DI |
|---|---|---|---|---|---|---|---|
| 1 | REVEAL DX | IMPLANTABLE LOOP RECORDER | DSI | MEDTRONIC MED REL, INC. | 9528 | ASKU |
Patients
| Seq | Age | Sex | Outcome | Treatment |
|---|---|---|---|---|
| 1 | 85 YR | Required Intervention |